gallium Ga 68 gozetotide (generic Ga-68 PSMA-11): FDA status

Approved Approved Jun 10, 2026. Indication: PSMA PET imaging in prostate cancer.

Regulatory history

All products in the FDA Tracker

Loading today's edition…